The TOR pathway interacts with the insulin signaling pathway to regulate C. elegans larval development, metabolism and life span

Development

Volumn 131, Issue 16, 2004, Pages 3897-3906

  Jia, Kailiang ^a   Chen, Di ^a   Riddle, Donald L ^a  

^a UNIVERSITY OF MISSOURI   (United States)

Author keywords

Aging; daf 15; Dauer formation; Insulin; Raptor; TOR

Indexed keywords

INSULIN; SOMATOMEDIN; TARGET OF RAPAMYCIN KINASE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR DAF 16; TRANSCRIPTION FACTOR FKHR; UNCLASSIFIED DRUG;

ARTICLE; CAENORHABDITIS ELEGANS; CELL GROWTH; CONTROLLED STUDY; GEL MOBILITY SHIFT ASSAY; GENE INTERACTION; GENE MAPPING; GENE MUTATION; GENE STRUCTURE; GENETIC CODE; GENETIC CONSERVATION; LARVAL DEVELOPMENT; LIFESPAN; METABOLIC PARAMETERS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSCRIPTION REGULATION;

ANIMALS; CAENORHABDITIS ELEGANS; CAENORHABDITIS ELEGANS PROTEINS; INSULIN; MOLECULAR SEQUENCE DATA; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); PROTEINS; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

CAENORHABDITIS; CAENORHABDITIS ELEGANS; MAMMALIA; NEMATODA; RAPTORES; TOR;

EID: 4544311861     PISSN: 09501991     EISSN: None     Source Type: Journal    
DOI: 10.1242/dev.01255     Document Type: Article

References (47)

1. Abraham, R. T. (2002). Identification of TOR signaling complexes: more TORC for the cell growth engine. Cell 111, 9-12.
2. Albert, P. S. and Riddle, D. L. (1988). Mutants of Caenorhabditis elegans that form dauer-like larvae. Dev. Biol. 126, 270-293.
3. Bergamini, E., Cavallini, G., Donati, A. and Gori, Z. (2003). The anti-ageing effects of caloric restriction may involve stimulation of macroautophagy and lysosomal degradation, and can be intensified pharmacologically. Biomed. Pharmacother. 57, 203-208.
4. Brenner, S. (1974). The genetics of Caenorhabditis elegans. Genetics 77, 71-94.
5. Brunk, U. T. and Terman, A. (2002). The mitochondrial-lysosomal axis theory of aging: accumulation of damaged mitochondria as a result of imperfect autophagocytosis. Eur. J. Biochem. 269, 1996-2002.
6. Chalfie, M., Tu, Y., Euskirchen, G., Ward, W. W. and Prasher, D. C. (1994). Green fluorescent protein as a marker for gene expression. Science 263, 802-805.
7. Chen, J., Zheng, X. F., Brown, E. J. and Schreiber, S. L. (1995). Identification of an 11-kDa FKBP12-rapamycin-binding domain within the 289-kDa FKBP12-rapamycin-associated protein and characterization of a critical serine residue. Proc. Natl. Acad. Sci. USA 92, 4947-4951.
8. Choi, J., Chen, J., Schreiber, S. L. and Clardy, J. (1996). Structure of the FKBP12-rapamycin complex interacting with the binding domain of human FRAP. Science 273, 239-242.
9. Chomczynski, P. and Sacchi, N. (1987). Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162, 156-159.
10. Conlon, I. and Raff, M. (1999). Size control in animal development. Cell 96, 235-244.
11. Fire, A., Xu, S., Montgomery, M. K., Kostas, S. A., Driver, S. E. and Mello, C. C. (1998). Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391, 806-811.
12. Gems, D., Sutton, A. J., Sundermeyer, M. L., Albert, P. S., King, K. V., Edgley, M. L., Larsen, P. L. and Riddle, D. L. (1998). Two pleiotropic classes of daf-2 mutation affect larval arrest, adult behavior, reproduction and longevity in Caenorhabditis elegans. Genetics 150, 129-155.
13. Hara, K., Maruki, Y., Long, X., Yoshino, K., Oshiro, N., Hidayat, S., Tokunaga, C., Avruch, J. and Yonezawa, K. (2002). Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action. Cell 110, 177-189.
14. Heitman, J., Movva, N. R. and Hall, M. N. (1991). Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast. Science 253, 905-909.
15. Holzenberger, M., Dupont, J., Ducos, B., Leneuve, P., Geloen, A., Even, P. C., Cervera, P. and le Bouc, Y. (2003). IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice. Nature 421, 182-187.
16. Huang, S. and Houghton, P. J. (2003). Targeting mTOR signaling for cancer therapy. Curr. Opin. Pharmacol. 3, 371-377.
17. Jia, K., Albert, P. S. and Riddle, D. L. (2002). DAF-9, a cytochrorne P450 regulating C. elegans larval development and adult longevity. Development 129, 221-231.
18. Kamath, R. S., Martinez-Campos, M., Zipperlen, P., Fraser, A. G. and Ahringer, J. (2000). Effectiveness of specific RNA-mediated interference through ingested double-stranded RNA in Caenorhabditis elegans. Genome Biol. 2, 1-10.
19. Kenyon, C., Chang, J., Gensch, E., Rudner, A. and Tabtiang, R. (1993). A C. elegans mutant that lives twice as long as wild type. Nature 366, 461-464.
20. Kenyon, C. (1997). Environmental factors and gene activities that influence life span. In C. elegans II (ed. D. L. Riddle, T. Blumenthal, B. J. Meyer and J. R. Priess), pp. 791-813. New York, NY: Cold Spring Harbor Laboratory Press.
21. Kim, D. H., Sarbassov, D. D., Ali, S. M., King, J. E., Latek, R. R., Erdjument-Bromage, H., Tempst, P. and Sabatini, D. M. (2002). mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery. Cell 110, 163-175.
22. Kimura, K. D., Tissenbaum, H. A., Liu, Y. and Ruvkun, G. (1997). daf-2, an insulin receptor-like gene that regulates longevity and diapause in Caenorhabditis elegans. Science 277, 942-946.
23. Klass, M. R. (1977). Ageing in the nematode Caenorhabditis elegans: major biological and environmental factors influencing life span. Mech. Ageing Dev. 6, 413-429.
24. Lakowski, B. and Hekimi, S. (1998). The genetics of caloric restriction in Caenorhabditis elegans. Proc. Natl. Acad. Sci. USA 95, 13091-13096.
25. Larsen, P. L., Albert, P. S. and Riddle, D. L. (1995). Genes that regulate both development and longevity in Caenorhabditis elegans. Genetics 139, 1567-1583.
26. Lee, S. S., Kennedy, S., Tolonen, A. C. and Ruvkun, G. (2003). DAF-16 target genes that control C. elegans life-span and metabolism. Science 300, 644-647.
27. Lin, K., Dorman, J. B., Rodan, A. and Kenyon, C. (1997). daf-16: an HNF-3/forkhead family member that can function to double the life-span of Caenorhabditis elegans. Science 278, 1319-1322.
28. Long, X., Spycher, C., Han, Z. S., Rose, A. M., Muller, F. and Avruch, J. (2002). TOR deficiency in C. elegans causes developmental arrest and intestinal atrophy by inhibition of mRNA translation. Curr. Biol. 12, 1448-1461.
29. Melendez, A., Talloczy, Z., Seaman, M., Eskelinen, E. L., Hall, D. H. and Levine, B. (2003). Autophagy genes are essential for dauer development and life-span extension in C. elegans. Science 301, 1387-1391.
30. Morris, J. Z., Tissenbaum, H. A. and Ruvkun, G. (1996). A phosphatidylinositol-3-OH kinase family member regulating longevity and diapause in Caenorhabditis elegans. Nature 382, 536-539.
31. Murphy, C. T., McCarroll, S. A., Bargmann, C. I., Fraser, A., Kamath, R. S., Ahringer, J., Li, H. and Kenyon, C. (2003). Genes that act downstream of DAF-16 to influence the lifespan of Caenorhabditis elegans. Nature 424, 277-283.
32. Neshat, M. S., Mellinghoff, I. K., Tran, C., Stiles, B., Thomas, G., Petersen, R., Frost, P., Gibbons, J. J., Wu, H. and Sawyers, C. L. (2001). Enhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP/mTOR. Proc. Natl. Acad. Sci. USA 98, 10314-10319.
33. O'Brien, R. M., Streeper, R. S., Ayala, J. E., Stadelmaier, B. T. and Hornbuckle, L. A. (2001). Insulin-regulated gene expression. Biochem. Soc. Trans. 29, 552-558.
34. Ogg, S. and Ruvkun, G. (1998). The C. elegans PTEN homolog, DAF-18, acts in the insulin receptor-like metabolic signaling pathway. Mol. Cell 2, 887-893.
35. Ogg, S., Paradis, S., Gottlieb, S., Patterson, G. I., Lee, L. Tissenbaum, H. A. and Ruvkun, G. (1997). The Fork head transcription factor DAF-16 transduces insulin-like metabolic and longevity signals in C. elegans. Nature 389, 994-999.
36. Oldham, S. and Hafen, E. (2003). Insulin/IGF and target of rapamycin signaling: a TOR de force in growth control. Trends Cell Biol. 13, 79-85.
37. Oldham, S., Montagne, J., Radimerski, T., Thomas, G. and Hafen, E. (2000). Genetic and biochemical characterization of dTOR, the Drosophila homolog of the target of rapamycin. Genes Dev. 14, 2689-2694.
38. +/- mice. Proc. Natl. Acad. Sci. USA 98, 10320-10325.
39. Puig, O., Marr, M. T., Ruhf, M. L. and Tjian, R. (2003). Control of cell number by Drosophila FOXO: downstream and feedback regulation of the insulin receptor pathway. Genes Dev. 17, 2006-2020.
40. Riddle, D. L. and Albert, P. S. (1997). Genetic and environmental regulation of dauer larva development. In C. elegans II (ed. D. L. Riddle, T. Blumenthal, B. J. Meyer and J. R. Priess), pp. 739-768. New York, NY: Cold Spring Harbor Laboratory Press.
41. Schmelzle, T. and Hall, M. N. (2000). TOR, a central controller of cell growth. Cell 253, 103-262.
42. Stan, R., McLaughlin, M. M., Cafferkey, R., Johnson, R. K., Rosenberg, M. and Livi, G. P. (1994). Interaction between FKBP12-rapamycin and TOR involves a conserved serine residue. J. Biol. Chem. 269, 32027-32030.
43. Tatar, M., Kopelman, A., Epstein, D., Tu, M. P., Yin, C. M. and Garofalo, R. S. (2001). A mutant Drosophila insulin receptor homolog that extends life-span and impairs neuroendocrine function. Science 292, 107-110.
44. Vellai, T., Takacs-Vellai, K., Zhang, Y., Kovacs, A. L., Orosz, L. and Muller, F. (2003). Genetics: influence of TOR kinase on lifespan in C. elegans. Nature 426, 620.
45. Wedaman, K. P., Reinke, A., Anderson, S., Yates, J. III, McCaffery, J. M. and Powers, T. (2003). Tor kinases are in distinct membrane-associated protein complexes in Saccharomyces cerevisiae. Mol. Biol. Cell 14, 1204-1220.
46. Wicks, S. R., Yeh, R. T., Gish, W. R., Waterston, R. H. and Plasterk, R. H. (2001). Rapid gene mapping in Caenorhabditis elegans using a high density polymorphism map. Nat. Genet. 28, 160-164.
47. Zhang, H., Stallock, J. P., Ng, J. C., Reinhard, C. and Neufeld, T. P. (2000). Regulation of cellular growth by the Drosophila target of rapamycin dTOR. Genes Dev. 14, 2712-2724.